Scroll Back to Top
Accessibility
Accessibility

28–30 June 2022

Precision Medicine World Conference (PMWC)

In-person

Silicon Valley Convention Center
Santa Clara, CA

Register

19–20 May 2022

Personalized Medicine Conference

In-person

Ritz Carlton Laguna Niguel
Dana Point, CA

Register

3–7 June 2022

American Society of Clinical Oncology (ASCO) Annual Meeting 2022

In-Person and Online

McCormick Place
Chicago, IL

Abstracts at ASCO

Register

8–13 April 2022

American Association for Cancer Research (AACR) Annual Meeting 2022

Decoding Cancer Complexity | Integrating Science | Transforming Patient Outcomes

Ernest N. Morial Convention Center
New Orleans, Louisiana

Register

2–4 March 2022

Association of Community Cancer Centers (ACCC) 48th Annual Meeting & Cancer Business Summit

Hybrid | In-Person and Live-Streaming

Washington, DC

Register

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

Read more »
Press Release
<span>Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services</span>
December 23, 2021

Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 23, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
Read more »
Subscribe to